CIK 0001829635
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Transcode Therapeutics, Inc.
Sign in to watch- Ticker
- RNAZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811065054
- Phone
- +1 857-301-6857
- Business address
- 6 LIBERTY SQUARE, #2382, BOSTON, MA, 02109
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | DEFJ, LLC 10% owner | Conversion | +11,813,859 | 12,113,899 | ||
| 2026-08-03 | DEFJ, LLC 10% owner | Conversion | +2,020,582 | 14,134,481 | ||
| 2026-08-03 | DEFJ, LLC 10% owner | Conversion · Series A Non-Voting Convertible Preferred Stock | −1,181.39 | 0 | ||
| 2026-08-03 | DEFJ, LLC 10% owner | Conversion · Series B Non-Voting Convertible Preferred Stock | −202.06 | 0 |
Page 1 of 1 · 4 trades